Sapporo Clinical Laboratory Inc. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sapporo Clinical Laboratory Inc. with three other
drug stores in Asia:
Apex Healthcare Bhd
sales of 620.26 million Malaysian Ringgits [US$159.49 million]
Great Tree Pharmacy Co Ltd
(3.62 billion Taiwanese Dollars [US$123.42 million]
Zhongzhi Pharmaceutical Holdings Ltd
based in Hong Kong
(1.09 billion Hong Kong Dollars [US$139.28 million]
of which 54%
was Pharmaceutical manufacturing).
During the year ended March of 2017, sales at
Sapporo Clinical Laboratory Inc. were ¥17.06 billion (US$159.30 million).
decrease of 2.7%
versus 2016, when the company's sales were ¥17.53 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Sapporo Clinical Laboratory Inc. had sales
of ¥15.54 billion.
Contributing to the drop in overall sales was the 7.9% decline
in Medical Equipment Sales and Maintenance , from ¥1.02 billion to ¥941.74 million.
There were also decreases in sales in
Dispensing Pharmacy Business (down 4.0% to ¥10.57 billion)
However, these declines were partially offset by the increase in sales of
Clinical Testing Business (up 0.9% to ¥5.48 billion)
Other Businesses (up 0.3% to ¥68.56 million)